Pfizer's ten nearest audiences are dominated by B2B consultancies and tech figures, not other pharmaceutical companies. Similarity here measures how closely two entities' audiences resemble each other in composition; a score near 0.96 indicates a very tight match.

The shape is flat: scores run from 0.97 down to 0.95 with no single neighbor pulling sharply ahead. IBM leads at 0.97, followed by Tim O'Reilly at 0.96 — a B2B technology brand and a tech personality, respectively, both ranking above any healthcare peer. Deloitte (0.96) and McKinsey & Company (0.96) round out a cluster of three B2B professional-services brands in the top 10. Tech personalities Marc Benioff (0.96) and Tim O'Reilly add a second cross-kind thread. Only two neighbors share Pfizer's own Healthcare subcategory: Novartis at 0.96 and GSK at 0.96 — present, but outnumbered. The remaining three slots go to media: Harvard Business Review (0.96), TechCrunch (0.95), and Forbes Tech (0.95) — all business and technology publications rather than health-focused outlets.

The overall picture is an audience shaped more by professional and enterprise-technology interests than by the healthcare sector alone.